High prevalence of coronary artery events and non-coronary events in patients with coronary artery aneurysm in the observational group. (March 2016)

• Record Type: Journal Article
• Authors: Warisawa, Takayuki; Naganuma, Toru; Tomizawa, Nobuo; Fujino, Yusuke; Ishiguro, Hisaaki; Tahara, Satoko; Kurita, Naoyuki; Nojo, Takeshi; Nakamura, Shotaro; Nakamura, Sunao
• Is Part Of: IJC heart & vasculature. Volume 10(2016)
• Page Start: 29
• Page End: 31
• Publication Date: 2016-03
• Subjects: Coronary artery aneurysm -- Cardiovascular events -- Prognosis -- Multi-detector computed tomography; Cardiovascular system -- Diseases -- Periodicals; Cardiovascular system -- Pathophysiology -- Periodicals; 616.1005
• DOI: 10.1016/j.ijcha.2015.10.005
• Languages: English
• ISSNs: 2352-9067

Abstract

Abstract: Background: Coronary artery aneurysm (CAA) is occasionally detected on a small percentage of coronary angiography or multi-detector computed tomography (MDCT). CAA itself is considered benign entity despite the potential risks of rupture, thromboembolism, and compression of surrounding structures. However, the optimal management including other vascular comorbidity has yet to be fully clarified. Objective: The aim of this study was to evaluate cardiovascular events in the patients with CAA in the observational group. Methods: Between January 2010 and August 2015, 48 CAAs were identified in 37 patients out of consecutive 10, 010 patients (0.37%) by MDCT. Twenty-eight patients treated conservatively were included in this study. Their major adverse cardiovascular events (MACE) were evaluated retrospectively: death, non-fatal myocardial infarction (MI), revascularizations; coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), and other vascular events. Results: The average age was 62.0 ± 15.5 year sold, and median follow-up period was 49.6 months (IQR 23.6 to 78.1). Mean CAA diameter was 7.5 ± 2.8 mm. Twenty-two MACE occurred in 15 patients (53.6%): 1 sudden death, 4 MI, 1 CABG for CAA, 3 PCI for CAA, 7 PCI for non-CAA lesions, and 6 other vascular treatments for aorta and cerebral and peripheral artery. Follow-up MDCT was performed for 22 CAAs in 16 patients. In 9 CAAs of them, the maximal diameter increased significantly (Δ diameter: 1.5 ± 1.1 mm). Conclusions: Presence of CAA may be associated with adverse vascular events including non-coronary diseases. This study could suggest the management for CAA should include the evaluation of not only CAA itself but also other vascular diseases.